ORION Trials: Efficacy and Safety Profile
ORION trials: efficacy and safety profile In patients with ASCVD or risk equivalents on a maximally tolerated statin in ORION-11, Leqvio®: 1,2 relative to placebo at Month 17, as compared with baseline (95% CI: −53.1 to −46.6; p < 0.0001) Similar...